These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32042784)

  • 1. The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up.
    Wu SG; Lian CL; Wang J; Zhang WW; Sun JY; Lin Q; He ZY
    Ann Transl Med; 2019 Dec; 7(23):768. PubMed ID: 32042784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph Node Status and Outcomes for Nasopharyngeal Carcinoma According to Histological Subtypes: A SEER Population-Based Retrospective Analysis.
    Guo R; Wu H; Wang J; Lian CL; He ZY; Zhang WW; Chen YX; Wu SG
    Adv Ther; 2019 Nov; 36(11):3123-3133. PubMed ID: 31559602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
    Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
    Argirion I; Zarins KR; Suwanrungruang K; Pongnikorn D; Chitapanarux I; Sriplung H; Vatanasapt P; Rozek LS
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3291-3299. PubMed ID: 33247687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg J; Braunius WW; Stegeman I; Wegner I; de Bree R; Overbeek LI; Koljenović S; Willems SM
    Oral Oncol; 2016 May; 56():40-6. PubMed ID: 27086485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung squamous cell carcinoma: A postoperative recurrence analysis of keratinizing and nonkeratinizing subtypes.
    Chen R; Yang X; Ding Z; Zhu L; Lu S; Yu Y
    Eur J Surg Oncol; 2019 May; 45(5):838-844. PubMed ID: 30389303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology.
    Ou SI; Zell JA; Ziogas A; Anton-Culver H
    Ann Oncol; 2007 Jan; 18(1):29-35. PubMed ID: 17060483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival comparison of Three histological subtypes of lung squamous cell carcinoma: A population-based propensity score matching analysis.
    An N; Leng X; Wang X; Sun Y; Chen Z
    Lung Cancer; 2020 Apr; 142():13-19. PubMed ID: 32062199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Stepan KO; Mazul AL; Skillington SA; Paniello RC; Rich JT; Zevallos JP; Jackson RS; Pipkorn P; Massa S; Puram SV
    Head Neck; 2021 Jun; 43(6):1797-1811. PubMed ID: 33620125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and Significance of Notch1, P21WAF1 and involucrin in nasopharyngeal carcinoma].
    Wang M; Li JT; Zeng YX; Hou JH; Lin QQ
    Ai Zheng; 2005 Oct; 24(10):1230-4. PubMed ID: 16219138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of Death in Long-Term Nasopharyngeal Carcinoma Survivors.
    Yang SP; Rao MY; Chen QS; Zhou P; Lian CL; Wu SG
    Front Public Health; 2022; 10():912843. PubMed ID: 35875003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of combined surgical and radiotherapy treatment in nonmetastatic WHO I nasopharyngeal carcinoma patients.
    Wang ZM; Zhu SY; Wang Q; Duan CY; Liu SH; You R; Chen MY; Huang PY
    Acta Otolaryngol; 2024 Apr; 144(4):325-332. PubMed ID: 39033361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival comparison of different histological subtypes of oropharyngeal squamous cell carcinoma: A propensity-matched score analysis based on SEER database.
    Li T; Wang Y; Xiang X; Chen C
    Ear Nose Throat J; 2022 Nov; ():1455613221136360. PubMed ID: 36317416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 1-year mortality after radiotherapy for nasopharyngeal carcinoma: a population-based analysis.
    Wu SG; Zhang WW; Wang J; Lian CL; He ZY; Rong YM; Lin Q
    Future Oncol; 2019 Oct; 15(29):3357-3365. PubMed ID: 31411050
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethno-geographic distribution and histopathological classification of nasopharyngeal carcinoma in a single center in Nepal.
    Pandit S; Sapkota S; Adhikari A; Karki P; Yadav D; Shrestha R; Yogal R; Chalise S; Pathak R; Jha AK
    PLoS One; 2024; 19(5):e0304371. PubMed ID: 38820402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology.
    Arnold M; Wildeman MA; Visser O; Karim-Kos HE; Middeldorp JM; Fles R; Bing Tan I; Coebergh JW
    Oral Oncol; 2013 Mar; 49(3):237-43. PubMed ID: 23089459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma.
    Lee SW; Yang CC; Lai HY; Tsai HH; Yeh CF; Kuo YH; Kang NW; Chen TJ; Chang SL
    Clin Med Insights Oncol; 2022; 16():11795549221113244. PubMed ID: 35898392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of histological typing in nasopharyngeal carcinoma.
    Cheung F; Chan O; Ng WT; Chan L; Lee A; Pang SW
    Oral Oncol; 2012 May; 48(5):429-33. PubMed ID: 22177891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of nasopharyngeal carcinoma in Finland: A nationwide study.
    Ruuskanen M; Grenman R; Leivo I; Vahlberg T; Mäkitie A; Saarilahti K; Wigren T; Korpela M; Voutilainen L; Koivunen P; Irjala H; Minn H
    Acta Oncol; 2018 Feb; 57(2):251-256. PubMed ID: 28686479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.